Used in pharmaceutical research as a synthetic intermediate for developing drugs targeting the endocannabinoid system, particularly as an inhibitor of the enzyme monoacylglycerol lipase (MAGL), which regulates levels of 2-AG, a neurotransmitter involved in inflammation, pain, and neurological processes. This compound shows potential for developing treatments for chronic conditions such as Alzheimer's disease, Parkinson's disease, chronic pain, and depression. Researchers employ it in structure-activity relationship (SAR) studies to enhance the efficacy and specificity of MAGL inhibitors for future therapeutics.